Institute on Aging

The Next Frontier of Precision Medicine: Parkinson's Disease

Penn Medicine launched first-of-its-kind Parkinson's disease initiative to advance research and treatment

Precision medicine allows physicians to provide the most tailored diagnostic tools and treatments for patients. By knowing the nature of a disease with molecular-level accuracy, doctors can treat that root cause. Penn Medicine uses precision medicine to treat a wide variety of disorders, ranging from preterm birth to cancer to cardiovascular disease. With the newly-launched Molecular Integration in Neurological Diagnosis (MIND) Initiative, Penn is bringing the power of precision medicine to Parkinson’s disease research.

Full Penn Medicine News Release

• Penn Medicine doctor's 5K raises thousands each year to benefit Alzheimer's research
  09/20/18
  Dr. Patrick J. Brennan understands the difficulties that millions of Americans encounter as they helplessly watch Alzheimer's…
• Encouraging results from experimental Alzheimer's drug
  07/27/18
  Finding a cure for Alzheimer’s disease has proved elusive. The drugs currently on the market only manage the symptoms of…
• Targeting Multiple Pathological Proteins May Be Key to Treating Neurodegenerative Diseases
  07/06/18
  Proteinopathies, the misfolded proteins responsible for neuron deaths, have a claim to fame when it comes to rare neurodegenerative…

IOA Fellows

Join the nearly 200 Institute on Aging Fellows and Associate Fellows and experience robust collaborative opportunities in aging at Penn, for funding opportunity alerts, pilot research grant opportunities, and updates on IOA activities.